Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Garrido

Showing results (621-630 of 657) with videos related to

Pageof 66
Sort By:
ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.
Clinical Chemistry and Laboratory Medicine|December 4, 2024
Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)Antonio Leon-Justel, Carmen Navarro Bustos, Jose Angel Noval-Padillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 26, 2020
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practiceE Pérez-Ruiz, J Jiménez-Castro, M-A Berciano-Guerrero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 16, 2016
Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumorsA Carmona-Bayonas, P Jiménez-Fonseca, J Virizuela, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
The CRAS-EAHFE study: Characteristics and prognosis of acute heart failure episodes with cardiorenal-anaemia syndrome at the emergency departmentLluis Llauger, Javier Jacob, Pablo Herrero-Puente, et al.
Oncoimmunology|August 29, 2024
CD4<sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsAnaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, et al.
Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panelsJavier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Journal of the American Heart Association|April 23, 2025
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki DiseaseSimon Lee, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonistsDonald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Pageof 66

Showing results (621-630 of 657) with videos related to

Sort By:
Pageof 66
ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.
Clinical Chemistry and Laboratory Medicine|December 4, 2024
Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)Antonio Leon-Justel, Carmen Navarro Bustos, Jose Angel Noval-Padillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 26, 2020
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practiceE Pérez-Ruiz, J Jiménez-Castro, M-A Berciano-Guerrero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 16, 2016
Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumorsA Carmona-Bayonas, P Jiménez-Fonseca, J Virizuela, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
The CRAS-EAHFE study: Characteristics and prognosis of acute heart failure episodes with cardiorenal-anaemia syndrome at the emergency departmentLluis Llauger, Javier Jacob, Pablo Herrero-Puente, et al.
Oncoimmunology|August 29, 2024
CD4<sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsAnaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, et al.
Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panelsJavier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Journal of the American Heart Association|April 23, 2025
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki DiseaseSimon Lee, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonistsDonald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Pageof 66